Navigation

NOTICES

Minimum Levels of Controlled Substances or Their Metabolites in Blood to Establish Presence of Controlled Substance

[34 Pa.B. 919]

   Under 75 Pa.C.S. § 1547(c)(4) (relating to chemical testing to determine amount of alcohol or controlled substance), as amended by the act of September 30, 2003 (P. L. 120, No. 24), the Department of Health (Department) is publishing a notice of the minimum levels of Schedule I, II and III controlled substances or their biotransformation products (metabolites) that must be present in a person's blood for the test results to be admissible in a prosecution for a violation of 75 Pa.C.S. § 1543(b)(1.1), 75 Pa.C.S. § 3802(d)(1), (2) or (3) or 75 Pa.C.S. § 3808(a)(2)) (relating to driving while operating privilege is suspended or revoked; driving under influence of alcohol or controlled substance; and illegally operating a motor vehicle not equipped with ignition interlock).

   Although there are hundreds of controlled substances in Schedules I, II and III, detection limits are listed only for commonly abused controlled substances for which testing procedures are readily available. The minimum concentrations specified are those that can be reliably measured by laboratories approved by the Department to test blood for controlled substance content.

   Clinical laboratories that operate in this Commonwealth that perform analyses of blood to determine controlled substance content must be approved by the Department in accordance with 28 Pa. Code § 5.50 (relating to approval to provide special analytical services). The approval process is conducted in much the same manner as the Department's approval of laboratories to test blood for alcohol content, as described in Commonwealth v. Brown, 631 A.2d 1014 (Pa. Super. 1993). This approval process requires laboratories to demonstrate an acceptable level of proficiency in determining the presence of controlled substances or their metabolites in blood.

   This testing is a two-step process. The first step involves the screening of blood using a relatively rapid and inexpensive technique to presumptively determine which specimens may contain the substance or a metabolite of the substance for which the blood is screened. The second step utilizes a more sensitive and specific procedure to substantiate the presence and concentration of the substance or its metabolite that was presumptively detected in the initial screening procedure.

   Confirmatory analyses employed to substantiate the presence of a drug or drug metabolite generally focus on identifying and quantitatively determining the concentration of the parent drug or a primary metabolite if extensive biotransformation occurs. The detection limits listed were developed by reviewing the minimum reportable concentrations for confirmatory analyses that laboratories in the Department's approval program specified they could measure. The concentrations listed are the levels that all laboratories approved by the Department to test blood for controlled substance content can reliably determine.

   The list contains only those substances that are included in the Department's proficiency testing program designed to provide assurance that laboratories approved to test blood for controlled substance content can reliably identify and measure the concentrations of drugs and their metabolites in blood. The Department will publish superseding notices as it determines the detection limits for other Schedule I, II and III controlled substances, or as the need otherwise arises.

   Persons with a disability who require an alternative format of this notice (for example, large print, audiotape or Braille) should contact Dr. M. Jeffery Shoemaker at V/TT (717) 783-6514 or by using the Pennsylvania AT&T Relay Service at (800) 654-5984 (TT).


Minimum Detection Limits
Class Substance Schedule (nanograms/milliliter)
Amphetamines
AmphetamineII  10
MethamphetamineII  10
Analgesics
Methadone II   50
Cannabinoids
Delta-9-carboxy THC* I     5
Cocaine
Cocaine II   20
Benzoylecgonine II   50
Hallucinogens
Phencyclidine II    5
Opiates
Codeine II   10
Hydrocodone II   10
Hydromorphone II   10
6-Monoacetylmorphine II   10
Morphine II   10
Oxycodone II   10
Sedatives/Hypnotics
Amobarbital II 200
Pentobarbital II 200
Secobarbital II 200

* THC = tetrahydrocannabinol

[Pa.B. Doc. No. 04-258. Filed for public inspection February 13, 2004, 9:00 a.m.]



No part of the information on this site may be reproduced for profit or sold for profit.

This material has been drawn directly from the official Pennsylvania Bulletin full text database. Due to the limitations of HTML or differences in display capabilities of different browsers, this version may differ slightly from the official printed version.


Navigation

webmaster@PaBulletin.com